Suspect Screening Analysis of Pooled Human Serum Samples Using GC × GC/TOF-MS.
Katherine A PhillipsAlex ChaoRebecca L ChurchKristin A FavelaStavros GarantziotisKristin K IsaacsBrian MeyerAnnette RiceRisa SayreBarbara A WetmoreAlice YauJohn F WambaughPublished in: Environmental science & technology (2024)
Humans interact with thousands of chemicals. This study aims to identify substances of emerging concern and in need of human health risk evaluations. Sixteen pooled human serum samples were constructed from 25 individual samples each from the National Institute of Environmental Health Sciences' Clinical Research Unit. Samples were analyzed using gas chromatography (GC) × GC/time-of-flight (TOF)-mass spectrometry (MS) in a suspect screening analysis, with follow-up confirmation analysis of 19 substances. A standard reference material blood sample was also analyzed through the confirmation process for comparison. The pools were stratified by sex (female and male) and by age (≤45 and >45). Publicly available information on potential exposure sources was aggregated to annotate presence in serum as either endogenous, food/nutrient, drug, commerce, or contaminant. Of the 544 unique substances tentatively identified by spectral matching, 472 were identified in females, while only 271 were identified in males. Surprisingly, 273 of the identified substances were found only in females. It is known that behavior and near-field environments can drive exposures, and this work demonstrates the existence of exposure sources uniquely relevant to females.
Keyphrases
- gas chromatography
- mass spectrometry
- drinking water
- health risk
- liquid chromatography
- tandem mass spectrometry
- high resolution mass spectrometry
- gas chromatography mass spectrometry
- high performance liquid chromatography
- human health
- capillary electrophoresis
- high resolution
- endothelial cells
- public health
- mental health
- healthcare
- ms ms
- health information
- air pollution
- optical coherence tomography
- solid phase extraction
- risk assessment
- phase iii
- clinical trial
- randomized controlled trial
- heavy metals
- magnetic resonance
- climate change